ACCESSION: MSBNK-SMB_Measured-HSA014P0439000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 28
COMMENT: RAW_SPEC {'Blanc1-neg_10318': {'bp': 329928.0, 'sum': 1027775.0}, 'Blanc1-neg_10351': {'bp': 275729.0, 'sum': 777333.0}, 'EL07-neg_10010': {'bp': 76229.0, 'sum': 214077.0}, 'EL13-neg_9995': {'bp': 71235.0, 'sum': 204554.0}, 'EL19-neg_10055': {'bp': 71162.0, 'sum': 227715.0}, 'EL05-neg_10045': {'bp': 71045.0, 'sum': 218533.0}, 'EL12-neg_10045': {'bp': 70226.0, 'sum': 216824.0}, 'EL18-neg_10001': {'bp': 69996.0, 'sum': 213940.0}, 'EL24-neg_9971': {'bp': 69458.0, 'sum': 206614.0}, 'EL06-neg_10044': {'bp': 69355.0, 'sum': 188560.0}, 'EL15-neg_10022': {'bp': 69341.0, 'sum': 222633.0}, 'Blanc2-neg_9942': {'bp': 67904.0, 'sum': 201863.0}, 'EL20-neg_10020': {'bp': 67380.0, 'sum': 214115.0}, 'EL09-neg_10008': {'bp': 67318.0, 'sum': 204507.0}, 'EL02-neg_10080': {'bp': 66187.0, 'sum': 200259.0}, 'EL17-neg_10019': {'bp': 66078.0, 'sum': 211861.0}, 'EL22-neg_10067': {'bp': 65868.0, 'sum': 194335.0}, 'EL03-neg_9986': {'bp': 64962.0, 'sum': 216249.0}, 'EL16-neg_9991': {'bp': 64844.0, 'sum': 214504.0}, 'EL10-neg_9991': {'bp': 64803.0, 'sum': 192418.0}, 'EL21-neg_10010': {'bp': 63063.0, 'sum': 216080.0}, 'EL23-neg_10004': {'bp': 62067.0, 'sum': 197331.0}, 'EL08-neg_9998': {'bp': 61383.0, 'sum': 175240.0}, 'Blanc3-neg_9944': {'bp': 60774.0, 'sum': 181913.0}, 'EL14-neg_9995': {'bp': 59239.0, 'sum': 210651.0}, 'EL01-neg_9984': {'bp': 59101.0, 'sum': 195418.0}, 'EL04-neg_9971': {'bp': 50224.0, 'sum': 157348.0}, 'EL11-neg_9983': {'bp': 47805.0, 'sum': 167937.0}}
COMMENT: RETENTION_TIME_STDEV 0.026
COMMENT: PRECURSOR_M/Z_RAW 439.306526
COMMENT: PRECURSOR_M/Z_STDEV 0.000229
COMMENT: PRECURSOR_IN_MS1 mz 439.306444; int 68.465; delta(ppm) 1.018024
COMMENT: PROPOSED_CHARGE_STATE -1; mz 440.309896; int 18.448; cor 0.790
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 3.182; C26H40N4O2; [M-H]1; delta(ppm) -3.181822
COMMENT: PROPOSED_MF SevenGoldenRules 0.143; C25H44O6; [M-H]1; delta(ppm) -0.143080
COMMENT: PROPOSED_MF SevenGoldenRules 2.203; C19H45N4O5P; [M-H]1; delta(ppm) 2.202975
COMMENT: PROPOSED_MF MS-FINDER 3.553; C25H44O6; [M-H]-; delta(ppm) -0.142733
COMMENT: PROPOSED_MF MS-FINDER 3.069; C26H40N4O2; [M-H]-; delta(ppm) -3.187099
COMMENT: PROPOSED_MF MS-FINDER 2.892; C19H45N4O5P; [M-H]-; delta(ppm) 2.209981
COMMENT: PROPOSED_MF MS-FINDER 2.650; C18H44N6O4S; [M-H]-; delta(ppm) -1.703828
COMMENT: PROPOSED_MF MS-FINDER 2.590; C18H52N2O3S3; [M-H]-; delta(ppm) -0.637613
COMMENT: PROPOSED_MF MS-FINDER 2.450; C11H44N12O2S2; [M-H]-; delta(ppm) -3.264919
COMMENT: PROPOSED_MF MS-FINDER 2.395; C11H36N16O3; [M-H]-; delta(ppm) -4.331128
COMMENT: PROPOSED_MF MS-FINDER 2.130; C14H40N12O2S; [M-H]-; delta(ppm) 4.408840
COMMENT: PROPOSED_MF MS-FINDER 2.083; C22H36N10; [M-H]-; delta(ppm) 2.925551
COMMENT: PROPOSED_MF MS-FINDER 2.052; C26H48OS2; [M-H]-; delta(ppm) -2.120887
COMMENT: PROPOSED_MF MS-FINDER 1.853; C19H40N10S; [M-H]-; delta(ppm) -4.748185
COMMENT: PROPOSED_MF SIRIUS5_Sirius 16.989; C25H44O6; [M-H]-; delta(ppm) -0.142733
COMMENT: PROPOSED_MF SIRIUS5_Sirius 10.048; C21H40N6O4; [M-H]-; delta(ppm) 5.969954
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.740; C26H40N4O2; [M-H]-; delta(ppm) -3.187099
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.999; C25H44O6; [M-H]-; delta(ppm) -0.142733
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.001; C21H40N6O4; [M-H]-; delta(ppm) 5.969954
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.574; C25H44O6; [M-H]-; delta(ppm) -0.142733
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.633; C21H40N6O4; [M-H]-; delta(ppm) 5.969954
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.495; C26H40N4O2; [M-H]-; delta(ppm) -3.187099
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.049; C23H41FN4O3; [M-H]-; delta(ppm) -5.788116
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.137; C20H44N2O8; [M-H]-; delta(ppm) 9.014375
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.191; C23H43F3O4; [M-H]-; delta(ppm) 5.423515
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.358; C20H45ClN4O4; [M-H]-; delta(ppm) -51799.944878
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.818; C23H46F2O3S; [M-H]-; delta(ppm) 0.350777
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.549; C22H46ClFN2O3; [M-H]-; delta(ppm) -51810.516243
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.998; C25H44O6; [M-H]-; delta(ppm) -0.142733
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C26H40N4O2; [M-H]-; delta(ppm) -3.187099
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C21H40N6O4; [M-H]-; delta(ppm) 5.969954
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.093; DSURJIWBIRGZCR-UHFFFAOYSA-N; [M-H]-; O=C([O-])C1=C2CC3CCC(C)C2(CC1)C43C[N+](=CCC4CNC)C(=N)NC5CCCCC5
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.056; ROWZXOYQHRRAQS-UHFFFAOYSA-N; [M-H]-; O=C(O)C1=C2CC3CCC(C)C2(CC1)C43CN(C=CC4CNC)C(=N)NC5CCCCC5
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.611; ZISAHQWTSFATDH-QCFSQOJCNA-N; [M-H]-; CC(C)CC(=O)OC[C@]1(C)CCC[C@]2(C)[C@@H]1CC[C@]1(C)O[C@](CO)(CC[C@@H]21)[C@@H](O)CO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.432; MMJYNAIFRKURTQ-IYLDQQHLNA-N; [M-H]-; C\C(CC[C@@H]1[C@](C)(CC[C@@H]2C(C)(C)CCC[C@@]12C)O[C@H]1OC[C@H](O)[C@@H](O)C1O)=C/CO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.428; IWSLLWVEHDTIGC-GGTQDYQENA-N; [M-H]-; C[C@@](CC[C@@H]1[C@@](C)(O)CC[C@@H]2C(C)(C)CCC[C@@]12C)(O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)C=C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.754; NEFATOVKUPLRBU-RYALCUHJNA-N; [M-H]-; UNPD19830
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.726; MMJYNAIFRKURTQ-IYLDQQHLNA-N; [M-H]-; 8beta,15-Dihydroxy-ent-labda-13E-ene-8-O-beta-xylopyranoside
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.672; ZISAHQWTSFATDH-QCFSQOJCNA-N; [M-H]-; UNPD13036
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.666; IWSLLWVEHDTIGC-GGTQDYQENA-N; [M-H]-; UNPD140685
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.357; KXLSJQTXSAYFDL-UHFFFAOYNA-N; [M-H]-; Acetolein
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.357; DAYZEZNVBPBOQL-QXMHVHEDSA-N; [M-H]-; UNPD23717
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.159; ROWZXOYQHRRAQS-UHFFFAOYSA-N; [M-H]-; 1-(N-cyclohexylcarbamimidoyl)-10'-methyl-4-[(methylamino)methyl]-2,4-dihydro-1H-spiro[pyridine-3,11'-tricyclo[5.3.1.0?,?]undecan]-4'-ene-4'-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.118; DSURJIWBIRGZCR-UHFFFAOYSA-N; [M-H]-; CNP0430759
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.756; JTTPSRQRBBOCDL-UHFFFAOYSA-N; [M-H]-; 2-(4-{[(cyclohexylcarbamoyl)amino]methyl}-2-methyl-5-(propan-2-yl)cyclohex-2-en-1-yl)-N-[(pyridin-3-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.756; XDWWPMNXWIOXFG-UHFFFAOYSA-N; [M-H]-; 3-benzyl-1-({3-methyl-4-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-(propan-2-yl)cyclohex-2-en-1-yl}methyl)urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.371; RWZQKJWBMAVLCZ-UHFFFAOYSA-N; [M-H]-; 2-[4-(2-{4-[(cyclopropylformamido)methyl]-2-methyl-5-(propan-2-yl)cyclohex-2-en-1-yl}acetyl)piperazin-1-yl]piperidin-1-ium-3-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; DSURJIWBIRGZCR-UHFFFAOYSA-N; [M-H]-; CNP0430759
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NEFATOVKUPLRBU-RYALCUHJNA-N; [M-H]-; UNPD19830
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.968; ROWZXOYQHRRAQS-UHFFFAOYSA-N; [M-H]-; 1-(N-cyclohexylcarbamimidoyl)-10'-methyl-4-[(methylamino)methyl]-2,4-dihydro-1H-spiro[pyridine-3,11'-tricyclo[5.3.1.0?,?]undecan]-4'-ene-4'-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.411; MMJYNAIFRKURTQ-IYLDQQHLNA-N; [M-H]-; 8beta,15-Dihydroxy-ent-labda-13E-ene-8-O-beta-xylopyranoside
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.411; IWSLLWVEHDTIGC-GGTQDYQENA-N; [M-H]-; UNPD140685
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.376; ZISAHQWTSFATDH-QCFSQOJCNA-N; [M-H]-; UNPD13036
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.033; KXLSJQTXSAYFDL-UHFFFAOYNA-N; [M-H]-; Acetolein
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.033; DAYZEZNVBPBOQL-QXMHVHEDSA-N; [M-H]-; UNPD23717
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.028; XDWWPMNXWIOXFG-UHFFFAOYSA-N; [M-H]-; 3-benzyl-1-({3-methyl-4-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-(propan-2-yl)cyclohex-2-en-1-yl}methyl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.027; RWZQKJWBMAVLCZ-UHFFFAOYSA-N; [M-H]-; 2-[4-(2-{4-[(cyclopropylformamido)methyl]-2-methyl-5-(propan-2-yl)cyclohex-2-en-1-yl}acetyl)piperazin-1-yl]piperidin-1-ium-3-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.024; JTTPSRQRBBOCDL-UHFFFAOYSA-N; [M-H]-; 2-(4-{[(cyclohexylcarbamoyl)amino]methyl}-2-methyl-5-(propan-2-yl)cyclohex-2-en-1-yl)-N-[(pyridin-3-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; KXLSJQTXSAYFDL-UHFFFAOYSA-N; [M-H]-; 2,3-diacetyloxypropyl octadec-9-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.474; HRQQEXIVBZHHOQ-UHFFFAOYSA-N; [M-H]-; 2-[2-[2-[2-[2-(2-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.458; PITRRWWILGYENJ-UHFFFAOYSA-N; [M-H]-; 2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; FDCVNHXODOUTTB-NBHCHVEOSA-N; [M-H]-; 3-[(E)-[(2E)-1,2-diphenyl-2-[3-(trimethylazaniumyl)propoxyimino]ethylidene]amino]oxypropyl-trimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.028; NEFATOVKUPLRBU; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.336; DAYZEZNVBPBOQL; [M-H]-; Glyceryl diacetate 2-oleate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.461; KXLSJQTXSAYFDL; [M-H]-; Glyceryl 1-oleate, diacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -283.718; ZISAHQWTSFATDH; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -311.275; NQWLQRHDYSFURT; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -321.542; HRQQEXIVBZHHOQ; [M-H]-; 14-(Nonylphenoxy)-3,6,9,12-tetraoxatetradecan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -355.377; IWSLLWVEHDTIGC; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -378.009; MMJYNAIFRKURTQ; [M-H]-; (2S,3R,4S,5S)-2-[[(1R,2R,4aS,8aS)-1-[(E)-5-hydroxy-3-methylpent-3-enyl]-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-2-yl]oxy]oxane-3,4,5-triol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.163; NEFATOVKUPLRBU; [M-H]-; nan
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C25H43O6; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 17.198
MS$FOCUSED_ION: PRECURSOR_M/Z 439.306450
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001j-9206300000-23f7aca055d08e139fc4
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  81.0331543 999.0000 81.033144 0.5924 0.00 0.5678 28 ?
  82.0365334 48.1806 82.036524 1.3774 12.99 0.3626 25 ?
  125.0230991 333.5530 125.023156 0.8958 32.86 0.6306 28 ?
  267.2692618 113.4412 267.269603 1.3731 13.08 0.4183 25 f{C18H35O1}/-0.29ppm,p-C7H8O5
  395.3165122 564.5890 395.317005 0.7134 65.92 0.5788 28 f{C24H43O4}/-0.43ppm,p-C1O2
  396.3200107 139.8126 396.320504 1.5341 23.49 0.7596 20 ?
  439.3059619 391.0912 439.306491 1.1131 42.23 1.0000 27 f{C25H43O6}/-1.25ppm,p
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  81.033154 999.00 999
  82.036533 48.18 48
  125.023099 333.55 333
  267.269262 113.44 113
  395.316512 564.59 564
  396.320011 139.81 139
  439.305962 391.09 391
//
